Modafinil for Severe Fatigue in Inflammatory Bowel Disease: A Prospective Case Series
Fatigue is highly prevalent in patients with IBD, affecting 72% of patients with active inflammatory bowel disease (IBD) and 47% in remission, and is associated with poor quality of life and significantly wider costs.1 However, understanding the mechanisms of IBD fatigue remains limited, as reflecte...
Gespeichert in:
| Veröffentlicht in: | Clinical gastroenterology and hepatology 2024-08, Vol.22 (8), p.1737-1740 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1740 |
|---|---|
| container_issue | 8 |
| container_start_page | 1737 |
| container_title | Clinical gastroenterology and hepatology |
| container_volume | 22 |
| creator | Moulton, Calum D. Young, Allan H. Hart, Ailsa L. |
| description | Fatigue is highly prevalent in patients with IBD, affecting 72% of patients with active inflammatory bowel disease (IBD) and 47% in remission, and is associated with poor quality of life and significantly wider costs.1 However, understanding the mechanisms of IBD fatigue remains limited, as reflected in a lack of effective treatments.1 |
| doi_str_mv | 10.1016/j.cgh.2023.12.030 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2912526046</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1542356524000119</els_id><sourcerecordid>2912526046</sourcerecordid><originalsourceid>FETCH-LOGICAL-c396t-ee10acc12981c71e1e5e1e8c374a138b08b4aa21434ae9b17c5874dcd8bf154f3</originalsourceid><addsrcrecordid>eNp9kE1LAzEQhoMofv8AL5Kjl66ZJPulJ61WCxUF7Tlks7M1ZT9qsq3035vS6tFDmDC88zDzEHIBLAIGyfU8MrPPiDMuIuARE2yPHEMs-SBNQe7v_iJO4iNy4v2cMZ7LPD0kRyKDPBDiYzJ96Upd2dbWtOocfccVOqQj3dvZEqlt6bitat00uu_cmt5331jTB-tRe7yhd_TNdX6BprcrpMPQCwBn0Z-Rg0rXHs939ZRMR48fw-fB5PVpPLybDIzIk36ACEwbAzzPwKSAgHF4mRGp1CCygmWF1JqDFFJjXkBq4iyVpSmzogq3VeKUXG25C9d9LdH3qrHeYF3rFrulVzwHHvOEySREYRs1YWXvsFILZxvt1gqY2thUcxVsqo1NBVwFm2HmcodfFg2WfxO_-kLgdhvAcOTKolPeWGwNltYFK6rs7D_4H6GShGc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2912526046</pqid></control><display><type>article</type><title>Modafinil for Severe Fatigue in Inflammatory Bowel Disease: A Prospective Case Series</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Moulton, Calum D. ; Young, Allan H. ; Hart, Ailsa L.</creator><creatorcontrib>Moulton, Calum D. ; Young, Allan H. ; Hart, Ailsa L.</creatorcontrib><description>Fatigue is highly prevalent in patients with IBD, affecting 72% of patients with active inflammatory bowel disease (IBD) and 47% in remission, and is associated with poor quality of life and significantly wider costs.1 However, understanding the mechanisms of IBD fatigue remains limited, as reflected in a lack of effective treatments.1</description><identifier>ISSN: 1542-3565</identifier><identifier>ISSN: 1542-7714</identifier><identifier>EISSN: 1542-7714</identifier><identifier>DOI: 10.1016/j.cgh.2023.12.030</identifier><identifier>PMID: 38191015</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Fatigue - drug therapy ; Fatigue - etiology ; Female ; Humans ; Inflammatory Bowel Diseases - complications ; Inflammatory Bowel Diseases - drug therapy ; Male ; Middle Aged ; Modafinil - therapeutic use ; Prospective Studies ; Treatment Outcome ; Wakefulness-Promoting Agents - therapeutic use ; Young Adult</subject><ispartof>Clinical gastroenterology and hepatology, 2024-08, Vol.22 (8), p.1737-1740</ispartof><rights>2024 The Authors</rights><rights>Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c396t-ee10acc12981c71e1e5e1e8c374a138b08b4aa21434ae9b17c5874dcd8bf154f3</citedby><cites>FETCH-LOGICAL-c396t-ee10acc12981c71e1e5e1e8c374a138b08b4aa21434ae9b17c5874dcd8bf154f3</cites><orcidid>0000-0003-0880-4495</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.cgh.2023.12.030$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38191015$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Moulton, Calum D.</creatorcontrib><creatorcontrib>Young, Allan H.</creatorcontrib><creatorcontrib>Hart, Ailsa L.</creatorcontrib><title>Modafinil for Severe Fatigue in Inflammatory Bowel Disease: A Prospective Case Series</title><title>Clinical gastroenterology and hepatology</title><addtitle>Clin Gastroenterol Hepatol</addtitle><description>Fatigue is highly prevalent in patients with IBD, affecting 72% of patients with active inflammatory bowel disease (IBD) and 47% in remission, and is associated with poor quality of life and significantly wider costs.1 However, understanding the mechanisms of IBD fatigue remains limited, as reflected in a lack of effective treatments.1</description><subject>Adult</subject><subject>Fatigue - drug therapy</subject><subject>Fatigue - etiology</subject><subject>Female</subject><subject>Humans</subject><subject>Inflammatory Bowel Diseases - complications</subject><subject>Inflammatory Bowel Diseases - drug therapy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Modafinil - therapeutic use</subject><subject>Prospective Studies</subject><subject>Treatment Outcome</subject><subject>Wakefulness-Promoting Agents - therapeutic use</subject><subject>Young Adult</subject><issn>1542-3565</issn><issn>1542-7714</issn><issn>1542-7714</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LAzEQhoMofv8AL5Kjl66ZJPulJ61WCxUF7Tlks7M1ZT9qsq3035vS6tFDmDC88zDzEHIBLAIGyfU8MrPPiDMuIuARE2yPHEMs-SBNQe7v_iJO4iNy4v2cMZ7LPD0kRyKDPBDiYzJ96Upd2dbWtOocfccVOqQj3dvZEqlt6bitat00uu_cmt5331jTB-tRe7yhd_TNdX6BprcrpMPQCwBn0Z-Rg0rXHs939ZRMR48fw-fB5PVpPLybDIzIk36ACEwbAzzPwKSAgHF4mRGp1CCygmWF1JqDFFJjXkBq4iyVpSmzogq3VeKUXG25C9d9LdH3qrHeYF3rFrulVzwHHvOEySREYRs1YWXvsFILZxvt1gqY2thUcxVsqo1NBVwFm2HmcodfFg2WfxO_-kLgdhvAcOTKolPeWGwNltYFK6rs7D_4H6GShGc</recordid><startdate>20240801</startdate><enddate>20240801</enddate><creator>Moulton, Calum D.</creator><creator>Young, Allan H.</creator><creator>Hart, Ailsa L.</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0880-4495</orcidid></search><sort><creationdate>20240801</creationdate><title>Modafinil for Severe Fatigue in Inflammatory Bowel Disease: A Prospective Case Series</title><author>Moulton, Calum D. ; Young, Allan H. ; Hart, Ailsa L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c396t-ee10acc12981c71e1e5e1e8c374a138b08b4aa21434ae9b17c5874dcd8bf154f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adult</topic><topic>Fatigue - drug therapy</topic><topic>Fatigue - etiology</topic><topic>Female</topic><topic>Humans</topic><topic>Inflammatory Bowel Diseases - complications</topic><topic>Inflammatory Bowel Diseases - drug therapy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Modafinil - therapeutic use</topic><topic>Prospective Studies</topic><topic>Treatment Outcome</topic><topic>Wakefulness-Promoting Agents - therapeutic use</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moulton, Calum D.</creatorcontrib><creatorcontrib>Young, Allan H.</creatorcontrib><creatorcontrib>Hart, Ailsa L.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical gastroenterology and hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moulton, Calum D.</au><au>Young, Allan H.</au><au>Hart, Ailsa L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Modafinil for Severe Fatigue in Inflammatory Bowel Disease: A Prospective Case Series</atitle><jtitle>Clinical gastroenterology and hepatology</jtitle><addtitle>Clin Gastroenterol Hepatol</addtitle><date>2024-08-01</date><risdate>2024</risdate><volume>22</volume><issue>8</issue><spage>1737</spage><epage>1740</epage><pages>1737-1740</pages><issn>1542-3565</issn><issn>1542-7714</issn><eissn>1542-7714</eissn><abstract>Fatigue is highly prevalent in patients with IBD, affecting 72% of patients with active inflammatory bowel disease (IBD) and 47% in remission, and is associated with poor quality of life and significantly wider costs.1 However, understanding the mechanisms of IBD fatigue remains limited, as reflected in a lack of effective treatments.1</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>38191015</pmid><doi>10.1016/j.cgh.2023.12.030</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0003-0880-4495</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1542-3565 |
| ispartof | Clinical gastroenterology and hepatology, 2024-08, Vol.22 (8), p.1737-1740 |
| issn | 1542-3565 1542-7714 1542-7714 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2912526046 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | Adult Fatigue - drug therapy Fatigue - etiology Female Humans Inflammatory Bowel Diseases - complications Inflammatory Bowel Diseases - drug therapy Male Middle Aged Modafinil - therapeutic use Prospective Studies Treatment Outcome Wakefulness-Promoting Agents - therapeutic use Young Adult |
| title | Modafinil for Severe Fatigue in Inflammatory Bowel Disease: A Prospective Case Series |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T08%3A50%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Modafinil%20for%20Severe%20Fatigue%20in%20Inflammatory%20Bowel%20Disease:%20A%20Prospective%20Case%20Series&rft.jtitle=Clinical%20gastroenterology%20and%20hepatology&rft.au=Moulton,%20Calum%20D.&rft.date=2024-08-01&rft.volume=22&rft.issue=8&rft.spage=1737&rft.epage=1740&rft.pages=1737-1740&rft.issn=1542-3565&rft.eissn=1542-7714&rft_id=info:doi/10.1016/j.cgh.2023.12.030&rft_dat=%3Cproquest_cross%3E2912526046%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2912526046&rft_id=info:pmid/38191015&rft_els_id=S1542356524000119&rfr_iscdi=true |